Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Euronext Amsterdam  >  Esperite    ESP   NL0009272137

ESPERITE (ESP)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsCalendarCompany 
News SummaryMost relevantAll newsSector newsTweets

CRYO SAVE GROUP : -Save Group N.V.: Purchase Shares Chairman

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/03/2011 | 07:05am CEST

Cryo-Save Group N.V. (Euronext: CRYO, 'Cryo-Save', or 'the Group'), the leading international family stem cell bank, has been informed that Mr Johan Goossens, Chairman, purchased 16,700 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price of ?4.14 on 1 November 2011.

Following this purchase, Mr Johan Goossens is beneficially interested in 1,316,703 ordinary shares, representing approximately 14.1% of the Group's issued share capital.

Enquiries:

Cryo-Save Group + 31 (0) 575 548 998
Arnoud van Tulder, Chief Executive Officer
SPJ Financiële Communicatie (The Netherlands) +31 (0)20 647 8181
Kees Jongsma/Leon Melens

Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Sean Lunn
College Hill (UK) + 44 (0) 20 7457 2020
Rozi Morris/ Adrian Duffield

Free footage is available on www.videobankonline.com:
http://www.videobankonline.com/

About Cryo-Save (www.cryo-save.com/group:
http://www.cryo-save.com/group)

Cryo-Save, the leading international family stem cell bank, already stores more than 194,000 samples from cord blood and umbilical cord tissue for newborns and adipose tissue for adults. These stem cells can mean the difference between life and death in the case of future threats to the health of the donors. There are already several diseases that can be cured by the use of stem cells, and the number of treatments will only increase. The use of stem cells from adipose tissue is increasingly popular in plastic surgery. Driven by its international business strategy, Cryo-Save is now represented in over 40 countries on four continents, with ultra-modern processing and storage facilities in the United States, Belgium, Germany, Dubai, India, South Africa and France (validation in progress).

Click here for PDF press release:
http://hugin.info/143308/R/1560195/482625.pdf



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Cryo-Save Group N.V. via Thomson Reuters ONE

HUG#1560195
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ESPERITE
08/12 ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces ne..
08/11 ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces ne..
08/11 ESPERITE (ESP) : L1 Capital confirms its investment in Esperite and announces n..
07/05 ESPERITE (ESP) : L1 Capital subscribes to the fourth packed tranche of investmen..
06/15 ESPERITE (ESP) : L1 Capital subscribes to the third packed tranche of investment..
06/02 ESPERITE N : Stem Cell Banking Market 2017 - CCBC, Krio, CBR, ViaCord, Esperite,..
06/02 ESPERITE (ESP) : L1 Capital subscribes to the second packed tranche today, ahead..
06/01 ESPERITE N : (ESP) Q1 consolidated revenue higher compared to budget
06/01 ESPERITE N : (ESP) has concluded new agreements with its note holders
06/01 ESPERITE (ESP) : L1 Capital subscribes to the second packed tranche today, ahead..
More news
Chart ESPERITE
Duration : Period :
Esperite Technical Analysis Chart | ESP | NL0009272137 | 4-Traders
Technical analysis trends ESPERITE
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Managers
NameTitle
Frédéric Amar Chief Executive Officer & Executive Director
Gert-Jan van der Marel Chairman
Henk L. Hakvoort Director-Finance
Samuel Amar Head-Information Technology Department
Marcin Jurga Manager-Research & Development
Sector and Competitors
1st jan.Capitalization (M$)
ESPERITE-62.41%0
FRESENIUS MEDICAL CARE-1.73%28 533
HCA HEALTHCARE INC5.09%28 008
LABORATORY CORP. OF AMERICA HOLDINGS19.89%15 765
QUEST DIAGNOSTICS INC14.66%14 305
DAVITA INC-12.41%10 751